• China biotech Laekna snaps up Novartis PD-L1 cancer therapy

    5 days ago - By Fierce Biotech

    While all the rage seems to be focused on cell and gene therapies these days, Shanghai-based biotech Laekna still believes in the power of checkpoint inhibitors.
    Read more ...